
When Is the 'Right' Time to Get a Facelift?
But how young is too young? How do you know when it's the right—and wrong—time to get a facelift? There are a couple of things to consider before you go under the knife.
Is there a 'right' age to get a facelift?
When it comes to getting a facelift, your age doesn't really matter. The real dealbreaker, experts say, is your overall health and your facial structure. 'The physical state of the face is more important than the biological age when assessing if someone is a suitable candidate for a facelift,' says Yannis Alexandrides, MD, FACS, board-certified plastic surgeon and founder of 111 Harley St. 'Many factors affect how a face looks and how it ages. These include lifestyle choices, genetics, and in some cases conditions or diseases.'
'I've operated on patients in their 70s who were better surgical candidates than some in their 50s. As long as someone is healthy, has realistic expectations, and can safely undergo anesthesia, they can be a good candidate,' agrees Alexis Parcells, MD, board-certified plastic surgeon and founder of Parcells Plastic Surgery. 'A facelift at any age can be transformative when it's done for the right reasons.'
Dr. Parcells goes on to say that most of her patients who opt for this treatment are in their late 40s to early 60s. This is about the age where skin laxity, jowling, and deeper folds are more pronounced. Facelifts, she explains, are about addressing structural changes and not just surface-level tweaks. So, the best time to get one is when those major face changes begin to bother you.
…but you can be considered too young for one
While there is no ideal age to get a facelift, experts do think that there are instances where one can be too young to undergo this surgery. Mainly, if you aren't showing any signs of aging on your face. 'Anyone under 40 is usually too young,' says Dr. Parcells. 'At that point, most concerns can be addressed with non-invasive treatments like radiofrequency, microneedling, or filler. A facelift is surgery—and with that comes downtime, risks, and cost—so we want to make sure we're correcting actual descent of tissue, not just volume loss or skin quality.'
What makes you a good candidate for a facelift?
There are a couple of things your doctor will look for to determine if a facelift is the right treatment for you. Dr. Alexandrides lists deep nasolabial folds (a.k.a. smile lines), jowling, laxity of the skin on the face or the neck, drooping of the brows, or extensive wrinkling of the face as some of the skin concerns that a facelift is the ideal treatment for. As mentioned before, you'll want to be healthy overall to minimize complications during and post-surgery. On a psychological level, he says patients should have realistic expectations for the results.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


TechCrunch
19 minutes ago
- TechCrunch
Linda Yaccarino joins health tech platform eMed as CEO after leaving X
Linda Yaccarino's next role after departing X as CEO will be another chief executive role at eMed Population Health, an AI startup building a tech platform for patients using GLP-1s. Yaccarino was a longtime advertising executive at NBCUniversal, but left to join X as CEO for two years, where she managed to have a positive impact on the social network's troubled ad revenue model, despite her and Elon Musk's shared approach to minimizing content moderation. Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her 'undeniable ability to negotiate new partnerships' — it certainly also helps that her tenure at X made her well-known in the tech world, drawing more eyes toward the startup. eMed previously produced a tech platform that was designed to be used with at-home COVID-19 rapid antigen tests, guiding users through the process of administering these tests properly. Now, eMed is focused on GLP-1s, the class of drugs like Ozempic, which can be used for both weight management and treatment of type II diabetes. 'To be a leader in today's healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry,' Yaccarino said in a press release. 'We are very well-positioned to be that tenacious leader, striving toward our ultimate goal of improving global healthcare outcomes through our groundbreaking services and platforms.'


News24
21 minutes ago
- News24
Why do African elites seek medical treatment abroad?
Choosing where to seek medical help is a deeply private decision. But the numerous occasions African leaders have sought treatment abroad have thrown the spotlight on local healthcare investment. To a large extent, leaders are responsible for the development of proper health care for the citizens of their countries. The deaths of former leaders Muhammadu Buhari of Nigeria and Edgar Lungu of Zambia in foreign medical facilities have not calmed accusations that African leaders neglect public health systems in their own countries. 'The state of healthcare in Nigeria is deeply concerning. The biggest problem is infrastructure. There are no drugs and functional medical equipment,' Jamila Atiku, a researcher on public health in Nigeria, told DW. Low investment in public health Reasons for medical tourism include a lack of specialised treatment available locally, poorly equipped hospitals and security fears for politicians. READ | Nigeria's former president Buhari dies at 82 Another factor, according to Zimbabwean health rights advocate Chamunorwa Mashoko, is an over-reliance on foreign aid. 'Among African countries, over 32 out of 54 countries are not allocating significant budgets to health. This is motivated by overdependency on donor aid,' he told DW. 'Africa is failing to realise that foreign funding in health is just for diplomacy. Those assisting us with all that aid really has nothing to do with our health challenges,' Mashoko added. African countries receive more than $60 billion (€52 billion) in health funding, representing just a fraction of the total health financing needed for the continent. Under the 2001 Abuja Declaration, African Union (AU) member states committed to end the continent's health financing crisis by pledging to allocate 15% of their annual national budgets to healthcare. But over two decades later, only three countries, Rwanda, Botswana, and Cape Verde, have consistently met or exceeded the target. The World Health Organisation (WHO) reports that over 30 AU member states allocate less than 10% of their budget to healthcare, with some allocating as little as 5% to 7%. 'Nigeria has been fluctuating between 4%-6% of the annual budget,' said Atiku, adding that politicians are only concerned about other infrastructure development projects like roads. 'Doctors and healthcare professionals are always going on strike because they are underpaid.' Inadequate public financing of health has resulted in poorly run, underperforming health systems across many African countries. 'Over-reliance on external funding is highly unsustainable and inconsistent with achieving Universal Health Coverage,' said Itai Rusike, of the Zimbabwe-based Community Working Group on Health. 'The Abuja target of 15% allocation to health has remained an elusive target. It is now outdated given the population increase, huge disease burden and the levels of neglect of infrastructure and health worker retention,' Rusike added. Which medical services are sought abroad A chronic lack of specialised treatment and facilities is driving many African patients to seek medical treatment abroad. The sectors affected include oncology, cardiology, neurology, orthopaedics, organ transplants, fertility, and paediatrics for the management of rare genetic disorders. Over 300 000 Africans travel to India annually for medical services, spending more than $2 billion each year. India is said to be generating more than $6 billion each year from medical tourism. Projections show the Asian country could get $13 billion in medical tourism by 2026 under the 'Heal in India' initiative. Phill Magakoe/Gallo Images According to the African Journal of Hospitality, Tourism and Leisure, Nigerians are estimated to spend $1 billion annually on medical tourism. Sixty percent of that amount is spent on oncology, orthopaedics, nephrology, and cardiology. Additionally, the figure represents almost 20% of the annual public health expenditure that covers the salaries of health workers. An estimated 5 000 Nigerians fly out of the country monthly for medical treatment, many traveling to India. What needs to be done Some African health authorities argue they are doing their best to improve healthcare for their countries. 'There is room for improvement to fund the health sector. We are targeting to ensure by 2027 at least 17 000 primary healthcare facilities are functional in Nigeria,' Nigeria's Minister of State for Health and Social Welfare, Iziaq Adekunle Salako, told DW. 'There is not a health system in the world that is 100%. We believe we are headed in the right direction in implementing solutions.' Health experts say African governments need to build modern health facilities to offer services currently being outsourced abroad. 'Looking up to politicians will not work. Communities need to come together and pull resources to create health care systems that work for them,' health rights advocate Chamunorwa Mashoko told DW. In 2016, the continental lender Afreximbank launched a support facility to build specialised health facilities across Africa to reduce outbound medical tourism. The initial target would focus on establishing a centre of excellence for cancer patients. Tanzania, Nigeria, Kenya and Ghana were identified as suitable to host the facilities.
Yahoo
an hour ago
- Yahoo
From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health
Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services. Fellow Health provides clinical grade, mail-in analysis of male fertility and post-vasectomy status while committing to "privacy, convenience and timely results." Italready has a network of more than 2,500 fertility and urology providers nationwide and wants to "deepen its footprint" through expansion into employer-sponsored fertility benefits and "broader access initiatives." Don't Miss: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— led the latest funding round, in which asset management firm Forest Road participated for the first time. Forest Managing Partner of Life Sciences Bill Burkoth will join Fellow's board as part of the financing deal. Other investors since the initial round include Labcorp Venture Fund, Genoa Ventures and Mantis Venture Capital. "Fellow Health is exactly the kind of company we look for – operating in a large, overlooked market that's long overdue for disruption," Burkoth said in a statement. "With over 50,000 test results delivered so far this year, they've proven there is real demand for a better patient experience." Live sperm gets counted in fertility analysis. These cells can live three to days within the cervix, uterus and fallopian tubes, but usually die in under an hour outside a woman's body. The mail-in service addresses this time bomb with a "preservation solution designed to stabilize your sample and a gel pack that helps maintain a moderate temperature during transit." Mail-in post-vasectomy testing is less time critical because it counts both living and dead sperm. Trending: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can Fellow Health points to studies backing up its claim that it can provide "results on par with traditional one-hour semen analysis when analyzing samples received within 52 hours of when they were produced." It sells both testing products and a cryopreservation service without a doctor's prescription at its website. 'Male reproductive health should not be reactive or inaccessible,' Fellow CEO Brian Hogan said in the statement. 'We are on track to deliver over 40% year-over-year revenue growth, with a path to profitability in our fertility segment by 2026. This investment allows us to scale that vision and support both patients and providers with modern tools that work.'However, Fellow Health faces stiff competition in the male fertility space that could impact this optimistic revenue outlook. Rival Posterity Health booked $13 million in Series A funding earlier this year. The company partnered with Mark Cuban Cost Plus Drug Company in 2023 to provide access to treatments for infertility, sexual dysfunction and low testosterone. A year earlier, American telehealth provider Ro bought Dadi, another male fertility and sperm testing startup. Its reproduction preservation service for men looks like a direct competitor to Fellow Health's family of products. Ro has also made a splash in women's health, acquiring Modern Fertility in 2021. Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data